DEXCOM, INC. (DXCM) Gross Margin
- Gross margin · 12 months: Value 62.47%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 62.47% | Gross profit / revenue. Period ending 2026-06-30. $3.10B ÷ $4.97B × 100 ≈ 62.47% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 3.10B USD | Gross Profit |
| Revenue | 4.97B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.86B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $3.10B | $4.97B | $1.86B | 62.47% |
| 2026-03-31 | $2.96B | $4.82B | $1.85B | 61.50% |
| 2025-12-31 | $2.80B | $4.66B | $1.86B | 60.10% |
| 2025-09-30 | $2.67B | $4.52B | $1.85B | 59.01% |
| 2025-06-30 | $2.53B | $4.30B | $1.77B | 58.77% |
| 2025-03-31 | $2.47B | $4.15B | $1.68B | 59.43% |
| 2024-12-31 | $2.44B | $4.03B | $1.59B | 60.46% |
| 2024-09-30 | $2.44B | $3.95B | $1.51B | 61.68% |
| 2024-06-30 | $2.47B | $3.93B | $1.47B | 62.74% |
| 2024-03-31 | $2.39B | $3.80B | $1.41B | 62.82% |
| 2023-12-31 | $2.29B | $3.62B | $1.33B | 63.19% |
| 2023-09-30 | $2.17B | $3.40B | $1.23B | 63.87% |
| 2023-06-30 | $2.04B | $3.20B | $1.15B | 63.94% |
| 2023-03-31 | $1.95B | $3.02B | $1.07B | 64.44% |
| 2022-12-31 | $1.88B | $2.91B | $1.03B | 64.72% |
| 2022-09-30 | $1.81B | $2.79B | $978.40M | 64.97% |
| 2022-06-30 | $1.77B | $2.67B | $906.30M | 66.10% |
| 2022-03-31 | $1.73B | $2.57B | $837.60M | 67.44% |
| 2021-12-31 | $1.68B | $2.45B | $768.00M | 68.63% |
| 2021-09-30 | $1.61B | $2.32B | $712.20M | 69.29% |
| 2021-06-30 | $1.50B | $2.17B | $669.40M | 69.15% |
| 2021-03-31 | $1.37B | $2.03B | $659.10M | 67.48% |
| 2020-12-31 | $1.28B | $1.93B | $646.60M | 66.44% |
| 2020-09-30 | $1.19B | $1.82B | $630.30M | 65.38% |
| 2020-06-30 | $1.10B | $1.72B | $619.20M | 63.92% |
| 2020-03-31 | $1.02B | $1.60B | $581.40M | 63.68% |
| 2019-12-31 | $931.50M | $1.48B | $544.50M | 63.11% |
| 2019-09-30 | $845.00M | $1.35B | $506.20M | 62.54% |
| 2019-06-30 | $766.70M | $1.22B | $454.90M | 62.76% |
| 2019-03-31 | $713.80M | $1.13B | $413.90M | 63.30% |
| 2018-12-31 | $663.90M | $1.03B | $367.70M | 64.36% |
| 2018-09-30 | $594.60M | $914.60M | (m) | 65.01% |
| 2018-06-30 | $553.00M | $832.50M | (m) | 66.43% |
| 2018-03-31 | $516.90M | $760.60M | (m) | 67.96% |
| 2017-12-31 | $492.10M | $718.50M | (m) | 68.49% |
| 2017-09-30 | $455.30M | $668.70M | (m) | 68.09% |
| 2017-06-30 | $429.40M | $632.70M | (m) | 67.87% |
| 2017-03-31 | $397.40M | $599.40M | (m) | 66.30% |
| 2016-12-31 | $378.40M | $573.30M | (m) | 66.00% |
| 2016-09-30 | $352.90M | $532.90M | (m) | 66.22% |
| 2016-06-30 | $326.50M | $489.50M | (m) | 66.70% |
| 2016-03-31 | $307.00M | (m) | (m) | (m) |
| 2015-12-31 | $278.40M | $402.00M | (m) | 69.25% |
| 2015-09-30 | $246.60M | $355.50M | (m) | 69.37% |
| 2015-06-30 | $219.10M | $319.30M | (m) | 68.62% |
| 2015-03-31 | $193.00M | $284.90M | (m) | 67.74% |
| 2014-12-31 | $176.30M | $259.20M | (m) | 68.02% |
| 2014-09-30 | $151.00M | $226.60M | (m) | 66.64% |
| 2014-06-30 | $131.40M | $200.50M | (m) | 65.54% |
| 2014-03-31 | $113.40M | $177.50M | (m) | 63.89% |
| 2013-12-31 | $100.10M | $160.00M | (m) | 62.56% |
| 2013-09-30 | $83.60M | $141.60M | (m) | 59.04% |
| 2013-06-30 | $64.40M | $121.80M | (m) | 52.87% |
| 2013-03-31 | $53.70M | $109.40M | (m) | 49.09% |
| 2012-12-31 | $46.60M | $99.90M | (m) | 46.65% |
| 2012-09-30 | $39.73M | $89.06M | (m) | 44.61% |
| 2012-06-30 | $39.49M | $84.22M | (m) | 46.89% |
| 2012-03-31 | $40.12M | $82.19M | (m) | 48.81% |
| 2011-12-31 | $35.84M | $76.27M | (m) | 47.00% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
| 2011-03-31 | $20.10M | $53.26M | (m) | 37.74% |
| 2010-12-31 | $18.44M | $48.63M | (m) | 37.92% |
| 2010-09-30 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) |
| 2009-12-31 | $3.66M | $29.69M | (m) | 12.33% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |